 Anthony Saviola
Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crotalid Venoms | 14 | 2025 | 30 | 4.300 |
Why?
| | Crotalus | 14 | 2025 | 24 | 3.670 |
Why?
| | Snake Venoms | 12 | 2025 | 20 | 3.010 |
Why?
| | Proteomics | 21 | 2025 | 1188 | 2.740 |
Why?
| | Proteome | 10 | 2025 | 513 | 1.360 |
Why?
| | Disintegrins | 2 | 2016 | 6 | 0.930 |
Why?
| | Fibrinolytic Agents | 2 | 2025 | 297 | 0.850 |
Why?
| | Thrombosis | 3 | 2025 | 400 | 0.820 |
Why?
| | Colubridae | 3 | 2021 | 9 | 0.800 |
Why?
| | Blood Coagulation | 2 | 2025 | 274 | 0.800 |
Why?
| | Fibrinolysis | 1 | 2025 | 164 | 0.770 |
Why?
| | Peptides | 4 | 2025 | 1000 | 0.740 |
Why?
| | Antivenins | 4 | 2025 | 29 | 0.720 |
Why?
| | Head and Neck Neoplasms | 5 | 2024 | 561 | 0.710 |
Why?
| | Extracellular Matrix | 9 | 2025 | 563 | 0.710 |
Why?
| | Animals | 49 | 2026 | 38106 | 0.650 |
Why?
| | Neglected Diseases | 1 | 2020 | 5 | 0.620 |
Why?
| | Streptococcus pneumoniae | 3 | 2026 | 186 | 0.600 |
Why?
| | Metalloproteases | 4 | 2024 | 42 | 0.520 |
Why?
| | Cell Adhesion | 2 | 2016 | 451 | 0.520 |
Why?
| | L-Amino Acid Oxidase | 4 | 2019 | 5 | 0.510 |
Why?
| | Bacterial Proteins | 5 | 2026 | 968 | 0.500 |
Why?
| | Mass Spectrometry | 5 | 2023 | 732 | 0.500 |
Why?
| | Predatory Behavior | 2 | 2016 | 52 | 0.490 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 56 | 0.430 |
Why?
| | Elapid Venoms | 2 | 2025 | 13 | 0.430 |
Why?
| | Extracellular Matrix Proteins | 3 | 2025 | 156 | 0.420 |
Why?
| | Collagen Type I | 2 | 2025 | 143 | 0.400 |
Why?
| | Biological Evolution | 2 | 2017 | 468 | 0.390 |
Why?
| | Serine Proteases | 2 | 2026 | 26 | 0.380 |
Why?
| | Virulence Factors | 2 | 2026 | 175 | 0.370 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2025 | 293 | 0.360 |
Why?
| | Mice | 20 | 2026 | 18358 | 0.360 |
Why?
| | Vitronectin | 2 | 2025 | 7 | 0.340 |
Why?
| | Fibronectins | 2 | 2025 | 136 | 0.310 |
Why?
| | Phospholipases A2 | 5 | 2025 | 79 | 0.300 |
Why?
| | Melanoma | 1 | 2016 | 762 | 0.290 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2026 | 923 | 0.280 |
Why?
| | Hydrogels | 3 | 2025 | 701 | 0.280 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 735 | 0.270 |
Why?
| | Pancreatic Neoplasms | 3 | 2025 | 928 | 0.260 |
Why?
| | Viper Venoms | 2 | 2018 | 6 | 0.250 |
Why?
| | Fibrosis | 3 | 2024 | 561 | 0.250 |
Why?
| | Cell Line, Tumor | 7 | 2025 | 3551 | 0.250 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2019 | 331 | 0.250 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4568 | 0.250 |
Why?
| | Transcriptome | 2 | 2025 | 1042 | 0.250 |
Why?
| | Aminoacyltransferases | 1 | 2026 | 13 | 0.240 |
Why?
| | Proteolysis | 2 | 2025 | 172 | 0.240 |
Why?
| | Cysteine Endopeptidases | 1 | 2026 | 78 | 0.240 |
Why?
| | Photoreceptor Cells | 1 | 2026 | 18 | 0.240 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2026 | 29 | 0.230 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 1 | 2026 | 21 | 0.230 |
Why?
| | Toxins, Biological | 2 | 2023 | 12 | 0.230 |
Why?
| | Humans | 38 | 2026 | 145785 | 0.230 |
Why?
| | Female Urogenital Diseases | 1 | 2025 | 7 | 0.230 |
Why?
| | Niacinamide | 1 | 2026 | 104 | 0.230 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2025 | 14 | 0.230 |
Why?
| | Murinae | 1 | 2025 | 6 | 0.220 |
Why?
| | Collagen | 2 | 2025 | 457 | 0.220 |
Why?
| | Interleukin-15 | 1 | 2026 | 95 | 0.220 |
Why?
| | Blastocyst | 1 | 2025 | 50 | 0.220 |
Why?
| | Coral Snakes | 1 | 2025 | 3 | 0.220 |
Why?
| | Interleukin-2 | 2 | 2023 | 440 | 0.220 |
Why?
| | Factor XIII | 1 | 2025 | 15 | 0.220 |
Why?
| | Protein Phosphatase 1 | 1 | 2025 | 32 | 0.220 |
Why?
| | Mexico | 3 | 2025 | 233 | 0.220 |
Why?
| | Biomimetics | 1 | 2025 | 41 | 0.220 |
Why?
| | Serine Endopeptidases | 1 | 2026 | 129 | 0.220 |
Why?
| | Transcription Termination, Genetic | 1 | 2025 | 22 | 0.220 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.220 |
Why?
| | Mammary Glands, Human | 1 | 2025 | 68 | 0.210 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 33 | 0.210 |
Why?
| | Ephrin-B2 | 1 | 2024 | 45 | 0.210 |
Why?
| | Dystrophin | 1 | 2024 | 41 | 0.210 |
Why?
| | Prodrugs | 1 | 2025 | 52 | 0.210 |
Why?
| | Fibrin | 1 | 2025 | 84 | 0.210 |
Why?
| | Keto Acids | 1 | 2024 | 10 | 0.210 |
Why?
| | Embryonic Development | 1 | 2025 | 125 | 0.210 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2024 | 20 | 0.210 |
Why?
| | Biomimetic Materials | 1 | 2025 | 78 | 0.210 |
Why?
| | Myelodysplastic Syndromes | 1 | 2026 | 165 | 0.210 |
Why?
| | PPAR alpha | 1 | 2024 | 55 | 0.210 |
Why?
| | Oleic Acid | 1 | 2024 | 40 | 0.200 |
Why?
| | Snake Bites | 1 | 2024 | 24 | 0.200 |
Why?
| | Organoids | 1 | 2026 | 144 | 0.200 |
Why?
| | Reactive Oxygen Species | 4 | 2026 | 611 | 0.200 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 101 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.200 |
Why?
| | Hydroxamic Acids | 1 | 2024 | 94 | 0.200 |
Why?
| | Acetates | 1 | 2024 | 78 | 0.200 |
Why?
| | Lactation | 1 | 2025 | 193 | 0.200 |
Why?
| | Interleukin-7 | 1 | 2024 | 66 | 0.200 |
Why?
| | Macular Degeneration | 1 | 2026 | 191 | 0.200 |
Why?
| | Herpesvirus 3, Human | 2 | 2024 | 343 | 0.200 |
Why?
| | Lipid Droplets | 1 | 2023 | 21 | 0.200 |
Why?
| | Phenotype | 6 | 2023 | 3170 | 0.200 |
Why?
| | Indoles | 2 | 2025 | 507 | 0.200 |
Why?
| | Lethal Dose 50 | 2 | 2025 | 17 | 0.190 |
Why?
| | Birth Injuries | 1 | 2023 | 18 | 0.190 |
Why?
| | Retina | 1 | 2026 | 331 | 0.190 |
Why?
| | Regeneration | 1 | 2025 | 198 | 0.190 |
Why?
| | Necrosis | 1 | 2024 | 244 | 0.190 |
Why?
| | Milk, Human | 1 | 2025 | 175 | 0.190 |
Why?
| | Protein Isoforms | 1 | 2024 | 399 | 0.190 |
Why?
| | RNA Precursors | 1 | 2024 | 154 | 0.190 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2026 | 251 | 0.190 |
Why?
| | Vagina | 1 | 2025 | 203 | 0.190 |
Why?
| | High-Throughput Screening Assays | 1 | 2025 | 177 | 0.190 |
Why?
| | Hematopoietic Stem Cells | 1 | 2026 | 435 | 0.190 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 221 | 0.190 |
Why?
| | Herpes Zoster | 2 | 2024 | 319 | 0.190 |
Why?
| | Peptide Hydrolases | 1 | 2023 | 105 | 0.180 |
Why?
| | RNA Splicing | 1 | 2024 | 284 | 0.180 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 62 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2026 | 411 | 0.180 |
Why?
| | Osteoarthritis | 1 | 2025 | 201 | 0.180 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2668 | 0.180 |
Why?
| | Vascular Remodeling | 1 | 2024 | 209 | 0.180 |
Why?
| | Wound Healing | 1 | 2025 | 355 | 0.180 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2025 | 218 | 0.180 |
Why?
| | Gene Expression | 2 | 2025 | 1478 | 0.180 |
Why?
| | Staphylococcus aureus | 1 | 2026 | 454 | 0.180 |
Why?
| | Mice, Knockout | 3 | 2026 | 3130 | 0.180 |
Why?
| | Menopause | 1 | 2025 | 326 | 0.180 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 278 | 0.180 |
Why?
| | Progesterone | 1 | 2023 | 215 | 0.180 |
Why?
| | Myocardium | 2 | 2024 | 935 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.170 |
Why?
| | Osteoarthritis, Knee | 1 | 2025 | 281 | 0.170 |
Why?
| | RNA Polymerase II | 1 | 2025 | 350 | 0.170 |
Why?
| | MCF-7 Cells | 3 | 2018 | 133 | 0.170 |
Why?
| | Apoptosis | 3 | 2026 | 2445 | 0.170 |
Why?
| | Microglia | 1 | 2024 | 273 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 447 | 0.170 |
Why?
| | Cattle | 4 | 2025 | 946 | 0.160 |
Why?
| | Evolution, Molecular | 1 | 2024 | 494 | 0.160 |
Why?
| | Semen | 1 | 2020 | 24 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2025 | 740 | 0.150 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 574 | 0.150 |
Why?
| | Drug Discovery | 1 | 2021 | 153 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2023 | 335 | 0.150 |
Why?
| | Trimeresurus | 1 | 2019 | 1 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 883 | 0.150 |
Why?
| | Chromatin | 1 | 2023 | 553 | 0.140 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 52 | 0.140 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2601 | 0.140 |
Why?
| | Epithelial Cells | 1 | 2025 | 1135 | 0.140 |
Why?
| | Reptilian Proteins | 1 | 2018 | 3 | 0.140 |
Why?
| | Models, Biological | 1 | 2026 | 1764 | 0.140 |
Why?
| | Breast Neoplasms | 2 | 2025 | 2393 | 0.130 |
Why?
| | Proteins | 2 | 2023 | 1023 | 0.130 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 143 | 0.130 |
Why?
| | Metabolomics | 1 | 2023 | 733 | 0.130 |
Why?
| | Gryllidae | 1 | 2017 | 1 | 0.130 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1482 | 0.130 |
Why?
| | Southwestern United States | 1 | 2017 | 93 | 0.130 |
Why?
| | Mitochondria | 1 | 2024 | 994 | 0.130 |
Why?
| | Lizards | 1 | 2017 | 43 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 630 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1199 | 0.120 |
Why?
| | RNA | 1 | 2023 | 912 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 766 | 0.120 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1211 | 0.120 |
Why?
| | Adenylyl Cyclases | 1 | 2016 | 60 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 450 | 0.120 |
Why?
| | Integrin alphaVbeta3 | 1 | 2016 | 20 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1777 | 0.110 |
Why?
| | Substrate Specificity | 2 | 2026 | 387 | 0.110 |
Why?
| | Catalytic Domain | 2 | 2026 | 234 | 0.110 |
Why?
| | Female | 13 | 2025 | 79045 | 0.110 |
Why?
| | Neutralization Tests | 2 | 2025 | 76 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 572 | 0.110 |
Why?
| | Protein Binding | 3 | 2026 | 2240 | 0.110 |
Why?
| | DNA, Complementary | 1 | 2015 | 273 | 0.110 |
Why?
| | Geography | 1 | 2015 | 187 | 0.100 |
Why?
| | Phylogeny | 3 | 2025 | 917 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 337 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 322 | 0.100 |
Why?
| | Stroke | 1 | 2023 | 1271 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2219 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 82 | 0.100 |
Why?
| | Neoplasms | 2 | 2021 | 2913 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2024 | 1957 | 0.090 |
Why?
| | Chromatography, Gel | 1 | 2013 | 130 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2015 | 592 | 0.090 |
Why?
| | Molecular Weight | 1 | 2013 | 312 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2026 | 5995 | 0.090 |
Why?
| | Zinc | 1 | 2015 | 307 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 963 | 0.080 |
Why?
| | Swine | 2 | 2025 | 826 | 0.080 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.080 |
Why?
| | Male | 7 | 2025 | 73012 | 0.070 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2131 | 0.070 |
Why?
| | Immunotherapy | 2 | 2025 | 668 | 0.070 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 499 | 0.070 |
Why?
| | Heart Failure | 1 | 2022 | 2326 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2026 | 1361 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2883 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2016 | 2514 | 0.070 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2026 | 26 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2026 | 99 | 0.060 |
Why?
| | Signal Transduction | 3 | 2025 | 5226 | 0.060 |
Why?
| | PDZ Domains | 1 | 2026 | 12 | 0.060 |
Why?
| | Rats | 2 | 2025 | 5585 | 0.060 |
Why?
| | Exocrine Glands | 1 | 2025 | 5 | 0.060 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2026 | 196 | 0.060 |
Why?
| | Salivary Glands | 1 | 2025 | 36 | 0.050 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.050 |
Why?
| | Drug Liberation | 1 | 2025 | 36 | 0.050 |
Why?
| | Colorado | 1 | 2015 | 4556 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2026 | 222 | 0.050 |
Why?
| | Protein Multimerization | 1 | 2026 | 205 | 0.050 |
Why?
| | Naja | 1 | 2024 | 1 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2025 | 234 | 0.050 |
Why?
| | Elapidae | 1 | 2024 | 5 | 0.050 |
Why?
| | Serpins | 1 | 2024 | 28 | 0.050 |
Why?
| | Acute-Phase Proteins | 1 | 2024 | 66 | 0.050 |
Why?
| | Cell Death | 1 | 2026 | 382 | 0.050 |
Why?
| | RNA Splice Sites | 1 | 2024 | 51 | 0.050 |
Why?
| | Molecular Dynamics Simulation | 1 | 2026 | 265 | 0.050 |
Why?
| | Fenofibrate | 1 | 2024 | 28 | 0.050 |
Why?
| | Saccharomycetales | 1 | 2024 | 29 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2025 | 185 | 0.050 |
Why?
| | Drug Repositioning | 1 | 2024 | 39 | 0.050 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2024 | 29 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 104 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 94 | 0.050 |
Why?
| | Acrylamides | 1 | 2024 | 74 | 0.050 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 93 | 0.050 |
Why?
| | Species Specificity | 1 | 2025 | 546 | 0.050 |
Why?
| | Estrogen Receptor alpha | 1 | 2025 | 151 | 0.050 |
Why?
| | Corpus Luteum | 1 | 2023 | 23 | 0.050 |
Why?
| | Trypsin | 1 | 2023 | 75 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | HeLa Cells | 1 | 2025 | 632 | 0.050 |
Why?
| | Snakes | 1 | 2023 | 19 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.050 |
Why?
| | Protein Conformation | 1 | 2026 | 938 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 22 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 32 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2026 | 273 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 311 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 40 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 69 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 106 | 0.050 |
Why?
| | Keratinocytes | 1 | 2024 | 249 | 0.050 |
Why?
| | Hormones | 1 | 2023 | 135 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 220 | 0.050 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2023 | 177 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 209 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 160 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2025 | 741 | 0.050 |
Why?
| | Proteoglycans | 1 | 2023 | 112 | 0.050 |
Why?
| | Serine | 1 | 2023 | 143 | 0.050 |
Why?
| | Aminophenols | 1 | 2025 | 203 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 473 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2025 | 719 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2023 | 174 | 0.040 |
Why?
| | Exosomes | 1 | 2023 | 104 | 0.040 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 688 | 0.040 |
Why?
| | Workflow | 1 | 2023 | 183 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 318 | 0.040 |
Why?
| | Viral Proteins | 1 | 2024 | 350 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2025 | 635 | 0.040 |
Why?
| | Arginine | 1 | 2023 | 264 | 0.040 |
Why?
| | Sympatry | 1 | 2021 | 17 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2024 | 314 | 0.040 |
Why?
| | Plasma | 1 | 2023 | 223 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 367 | 0.040 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 266 | 0.040 |
Why?
| | Fatty Acids | 1 | 2024 | 457 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2024 | 544 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1708 | 0.040 |
Why?
| | Models, Molecular | 1 | 2026 | 1599 | 0.040 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2024 | 414 | 0.040 |
Why?
| | India | 1 | 2021 | 213 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 7216 | 0.040 |
Why?
| | Metabolome | 1 | 2023 | 391 | 0.040 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2020 | 27 | 0.040 |
Why?
| | Electron Transport | 1 | 2020 | 110 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2025 | 2525 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 546 | 0.040 |
Why?
| | Islands | 1 | 2019 | 3 | 0.040 |
Why?
| | Indonesia | 1 | 2019 | 23 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2019 | 59 | 0.040 |
Why?
| | Skin | 1 | 2024 | 754 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2110 | 0.040 |
Why?
| | Gelatin | 1 | 2019 | 56 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1454 | 0.030 |
Why?
| | Cytokines | 1 | 2026 | 2069 | 0.030 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1129 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2019 | 244 | 0.030 |
Why?
| | Caspase 8 | 1 | 2018 | 48 | 0.030 |
Why?
| | Caspase 9 | 1 | 2018 | 55 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 2022 | 429 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2018 | 74 | 0.030 |
Why?
| | Guam | 1 | 2017 | 17 | 0.030 |
Why?
| | Fibrinogen | 1 | 2019 | 180 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 686 | 0.030 |
Why?
| | Stem Cells | 1 | 2022 | 630 | 0.030 |
Why?
| | Introduced Species | 1 | 2017 | 39 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2865 | 0.030 |
Why?
| | Macrophages | 1 | 2025 | 1507 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1146 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2022 | 756 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2020 | 385 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2023 | 1166 | 0.030 |
Why?
| | Glutathione | 1 | 2018 | 370 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 748 | 0.030 |
Why?
| | Caspase 7 | 1 | 2015 | 22 | 0.030 |
Why?
| | Pakistan | 1 | 2015 | 79 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 762 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3752 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2885 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1791 | 0.020 |
Why?
| | Aging | 1 | 2024 | 1973 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1711 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3418 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2969 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3346 | 0.020 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 868 | 0.020 |
Why?
| | Aged | 1 | 2024 | 26217 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 36309 | 0.010 |
Why?
|
|
Saviola's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|